483 related articles for article (PubMed ID: 22639160)
1. Glioma antigen.
Toda M
Adv Exp Med Biol; 2012; 746():77-84. PubMed ID: 22639160
[TBL] [Abstract][Full Text] [Related]
2. Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients.
Harada M; Ishihara Y; Itoh K; Yamanaka R
Oncol Rep; 2007 Mar; 17(3):629-36. PubMed ID: 17273744
[TBL] [Abstract][Full Text] [Related]
3. Peptide vaccine.
Izumoto S
Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
[TBL] [Abstract][Full Text] [Related]
4. [Cellular immunotherapy for malignant glioma].
Okamoto Y; Yamashita J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
[No Abstract] [Full Text] [Related]
5. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.
Ueda R; Ohkusu-Tsukada K; Fusaki N; Soeda A; Kawase T; Kawakami Y; Toda M
Int J Cancer; 2010 Feb; 126(4):919-29. PubMed ID: 19728337
[TBL] [Abstract][Full Text] [Related]
6. In situ dendritic cell vaccination for the treatment of glioma and literature review.
Li M; Han S; Shi X
Tumour Biol; 2016 Feb; 37(2):1797-801. PubMed ID: 26318301
[TBL] [Abstract][Full Text] [Related]
7. Cellular immunity in the treatment of brain tumors.
Wheeler CJ; Yu JS; Black KL
Clin Neurosurg; 2004; 51():132-9. PubMed ID: 15571138
[No Abstract] [Full Text] [Related]
8. Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine.
Iizuka Y; Kojima H; Kobata T; Kawase T; Kawakami Y; Toda M
Int J Cancer; 2006 Feb; 118(4):942-9. PubMed ID: 16152596
[TBL] [Abstract][Full Text] [Related]
9. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.
Renner DN; Jin F; Litterman AJ; Balgeman AJ; Hanson LM; Gamez JD; Chae M; Carlson BL; Sarkaria JN; Parney IF; Ohlfest JR; Pirko I; Pavelko KD; Johnson AJ
PLoS One; 2015; 10(5):e0125565. PubMed ID: 25933216
[TBL] [Abstract][Full Text] [Related]
10. [Peptide vaccination therapy for malignant glioma].
Yamanaka R; Itoh K
Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
[TBL] [Abstract][Full Text] [Related]
11. Cellular immunotherapy for malignant gliomas.
Lin Y; Okada H
Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based immunotherapeutic approaches to glioma: a review.
Yamanaka R; Itoh K
Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
[TBL] [Abstract][Full Text] [Related]
13. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
[TBL] [Abstract][Full Text] [Related]
14. Glioma-specific antigens for immune tumor therapy.
Skog J
Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-based immunotherapy of malignant gliomas.
Parajuli P; Sloan AE
Cancer Invest; 2004; 22(3):405-16. PubMed ID: 15493362
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
Prins RM; Odesa SK; Liau LM
Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
[TBL] [Abstract][Full Text] [Related]
17. Immunological aspects of intrinsic glial tumors.
Apuzzo ML; Mitchell MS
J Neurosurg; 1981 Jul; 55(1):1-18. PubMed ID: 7017079
[No Abstract] [Full Text] [Related]
18. [Brain tumor immunotherapy: Illusion or hope?].
Migliorini D; Dutoit V; Walker PR; Dietrich PY
Bull Cancer; 2017 May; 104(5):476-484. PubMed ID: 28318492
[TBL] [Abstract][Full Text] [Related]
19. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
Yamanaka R; Xanthopoulos KG
DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
[TBL] [Abstract][Full Text] [Related]
20. Personalized, multivalent, and more affordable: the globalization of vaccines.
Debinski W
Clin Cancer Res; 2005 Aug; 11(16):5663-4. PubMed ID: 16115899
[No Abstract] [Full Text] [Related]
[Next] [New Search]